Respiratory Syncytial Virus Vaccine Shortage Spurs Revised Recommendations for Infant Protection
Previously, an advisory panel had suggested administering the monoclonal antibody shot Beyfortus to all infants below 8 months entering their first RSV season and to those aged 8 to 19 months at heightened risk during their second season. In response to a shortage of the Respiratory Syncytial Virus Vaccine, health authorities are revising their recommendations … Read more